ArticleJournal of health, population, and nutrition2025
Body composition mediates the association between fatty acids and NAFLD risk: a prospective cohort study.
Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study aimed to investigate how body composition, particularly adiposity distribution, mediates the association between circulating fatty acids (FAs) and the incidence of severe non-alcoholic fatty liver disease (NAFLD).
methodsIn the UK Biobank cohort, plasma FAs were measured using nuclear magnetic resonance spectroscopy in 107,593 participants at baseline. Cox regression models were utilized to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between FAs and the incidence of severe NAFLD. Additionally, mediation analyses were conducted to quantify the mediating effects of different body composition indices in these associations. Cross-sectional association of FAs with metabolic-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) were also explored by multivariate logistic regression.
resultsDuring an average follow-up period of 13.1 years, 1,480 severe NAFLD cases were identified. In multivariable analyses, the HRs per SD and CIs were 0.76 (95% CI: 0.68-0.86) for plasma polyunsaturated fatty acids (PUFA), 1.28 (95% CI: 1.12-1.46) for monounsaturated fatty acids (MUFA), and 1.20 (95% CI: 1.10-1.32) for saturated fatty acids (SFA) (all P < 0.001). Results for MAFLD and MASLD were comparable. SFA and MUFA were positively correlated, while PUFA was inversely correlated to all body composition indices. Mediation analysis revealed that central obesity indices, such as waist circumference and body roundness index, mediated 19-36% of the associations between FAs and severe NAFLD (all P < 0.001). Although other body composition indices also exhibited significant mediating effects, their contributions were relatively smaller. Specifically, leg fat mass index mediated around 13-26% and arm fat mass index mediated around 9-21% of the association between FAs and severe NAFLD.
conclusionThis study highlights that body compositions, particularly central obesity, may partially mediate the relationship between plasma FAs and the incidence of severe NAFLD, suggesting that dietary interventions, when integrated with broader strategies to reduce central adiposity, could be critical for preventing NAFLD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.